Integra Lifesciences Holdings Corp. (IART)
NASDAQ:IART
Holding IART?
Track your performance easily

Integra Lifesciences (IART) Financial Statements

235 Followers

Integra Lifesciences Financial Overview

Integra Lifesciences's market cap is currently ―. The company's EPS TTM is $-0.089; its P/E ratio is -286.31; Integra Lifesciences is scheduled to report earnings on February 19, 2025, and the estimated EPS forecast is $0.85. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue$ 380.83M$ 418.18M$ 368.87M$ 382.42M$ 381.27M
Gross Profit$ 200.24M$ 225.92M$ 206.83M$ 218.34M$ 207.03M
EBIT$ -20.36M$ -15.19M$ 8.39M$ 18.61M$ 3.82M
EBITDA$ 15.60M$ 21.59M$ 38.96M$ 49.17M$ 34.65M
Net Income Common Stockholders$ -10.70M$ -12.40M$ -3.28M$ 19.50M$ 16.65M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 277.60M$ 296.90M$ 663.10M$ 273.73M$ 309.19M
Total Assets$ 4.07B$ 4.07B$ 4.08B$ 3.74B$ 3.78B
Total Debt$ 1.99B$ 2.01B$ 2.04B$ 1.69B$ 1.60B
Net Debt$ 1.71B$ 1.71B$ 1.38B$ 1.41B$ 1.29B
Total Liabilities$ 2.54B$ 2.54B$ 2.48B$ 2.16B$ 2.09B
Stockholders Equity$ 1.52B$ 1.53B$ 1.60B$ 1.58B$ 1.68B
Cash Flow-
Free Cash Flow$ -7.16M$ 10.69M$ 291.00K$ 13.69M$ 12.73M
Operating Cash Flow$ 22.48M$ 40.40M$ 15.76M$ 26.77M$ 28.28M
Investing Cash Flow$ -10.40M$ -322.20M$ -53.97M$ -7.70M$ -15.55M
Financing Cash Flow$ -19.91M$ -93.75M$ 358.68M$ -49.66M$ -10.69M
Currency in USD

Integra Lifesciences Earnings and Revenue History

Integra Lifesciences Debt to Assets

Integra Lifesciences Cash Flow

Integra Lifesciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis